Announcements Trials
Browse Landscape

Status

Completed 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 19Observational 4

Sponsor

Cancer Type

Other solid neoplasm 4

Conditions

Mesothelioma 44Mesothelioma, Malignant 42Retinoblastoma 35Solid Tumor 27Lung Neoplasms 16Hematopoietic and Lymphatic System Neoplasm 16Pancreatic Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Unspecified Adult Solid Tumor, Protocol Specific 12Solid Tumors 11Solid Tumor, Adult 10Ovarian Neoplasms 10Neoplasms 10Sarcoma 9Melanoma 9Carcinoma, Renal Cell 9Thymus Neoplasms 8Stomach Neoplasms 8Esophageal Neoplasms 8Breast Neoplasms 8Small Cell Lung Carcinoma 7Colonic Neoplasms 7Urinary Bladder Neoplasms 6Prostatic Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Thymoma 5Neoplasms, Unknown Primary 5Kidney Neoplasms 5Cholangiocarcinoma 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Hematopoietic and Lymphoid System Neoplasm × Other solid neoplasm × Clear all
NCT06192875 2026-03-10

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

Mayo Clinic

Recruiting
10,000 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT05766332 2025-01-10

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

Mayo Clinic

Completed
137 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT06104657 2024-12-02

Qualitative Techniques to Define Meaningful Within-Patient Change in Symptoms of Advanced Cancer Patients

Mayo Clinic

Completed
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

NCT05717101 2024-09-24

Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging

Mayo Clinic

Completed
4 enrolled
Other solid neoplasm

Hematopoietic and Lymphoid System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡